MARKET

CFRXQ

CFRXQ

Contrafect Corp
EXMKT
0.0001
0.0000
0.00%
Closed 09:35 02/14 EST
OPEN
0.0001
PREV CLOSE
0.0001
HIGH
0.0001
LOW
0.0001
VOLUME
3.38K
TURNOVER
0
52 WEEK HIGH
0.033
52 WEEK LOW
0.0001
MARKET CAP
1.07K
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CFRXQ last week (0210-0214)?
Weekly Report · 20h ago
Weekly Report: what happened at CFRXQ last week (0203-0207)?
Weekly Report · 02/10 11:12
Weekly Report: what happened at CFRXQ last week (0127-0131)?
Weekly Report · 02/03 11:16
Weekly Report: what happened at CFRXQ last week (0120-0124)?
Weekly Report · 01/27 11:19
Weekly Report: what happened at CFRXQ last week (0113-0117)?
Weekly Report · 01/20 11:11
Weekly Report: what happened at CFRXQ last week (0106-0110)?
Weekly Report · 01/13 11:12
Weekly Report: what happened at CFRXQ last week (1230-0103)?
Weekly Report · 01/06 11:20
Weekly Report: what happened at CFRXQ last week (1223-1227)?
Weekly Report · 12/30/2024 11:14
More
About CFRXQ
ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase, is used for the treatment of methicillin-resistant S. aureus (MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its exebacase is being studied in an ongoing Phase Ib/II study in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumanni, and has demonstrated potent in vivo activity against these pathogens.

Webull offers ContraFect Corp stock information, including EXMKT: CFRXQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CFRXQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CFRXQ stock methods without spending real money on the virtual paper trading platform.